QuidelOrtho names Sanjeev Sharma vice president of investor relations
QDEL•QuidelOrtho appointed Sanjeev Sharma vice president of investor relations, effective Sept. 28, 2026.
QDEL•QDEL•QDEL•QuidelOrtho appointed Sanjeev Sharma vice president of investor relations, effective Sept. 28, 2026.
Sharma was senior director of investor relations at Teva Pharmaceuticals. Earlier, he held investor relations and business strategy roles at Genpact, after nearly six years in sell-side equity research.
